Literature DB >> 27075431

Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes.

D Andrew Tompkins1, Patrick S Johnson2, Michael T Smith1, Eric C Strain1, Robert R Edwards3, Matthew W Johnson1.   

Abstract

Opioid therapy for pain is associated with an increased risk for substance use disorders. This study's purpose was to determine the association between opioid misuse propensity (Screener and Opioid Assessment for Patients in Pain-Revised) and delay discounting (DD), a behavioral process linked to substance use disorders, which quantifies the extent to which outcomes are devalued because of their delay. Participants reporting chronic pain (N = 249) answered pain and opioid use questions and then completed 4 DD tasks. Each of these tasks assessed either money or pain consequences, framed as either rewards or punishments. Each task involved hypothetical choices between immediate smaller vs delayed larger consequences. The extant Monetary Choice Questionnaire assessed DD of money rewards, and a modified version assessed discounting of money losses (immediate smaller loss vs larger delayed loss). Based on the Monetary Choice Questionnaire, the novel Pain Relief Choice Questionnaire assessed choices between an immediate short duration of pain relief vs a longer duration of pain relief. Similarly, the novel Additional Pain Choice Questionnaire assessed choices between an immediate short duration of additional pain vs a longer duration of additional pain. Discounting of both additional pain and money losses were significantly associated with high Screener and Opioid Assessment for Patients in Pain-Revised scores-indicating participants at greatest risk for opioid misuse discount future punishments rather than future rewards compared with those at low risk. Measures of DD may have promise in more accurately identifying individuals at highest risk for opioid misuse during chronic opioid therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27075431      PMCID: PMC4949122          DOI: 10.1097/j.pain.0000000000000576

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  43 in total

1.  Mild opioid deprivation increases the degree that opioid-dependent outpatients discount delayed heroin and money.

Authors:  Louis A Giordano; Warren K Bickel; George Loewenstein; Eric A Jacobs; Lisa Marsch; Gary J Badger
Journal:  Psychopharmacology (Berl)       Date:  2002-07-13       Impact factor: 4.530

2.  The behavioral economics and neuroeconomics of reinforcer pathologies: implications for etiology and treatment of addiction.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

Review 3.  Reward and motivation in pain and pain relief.

Authors:  Edita Navratilova; Frank Porreca
Journal:  Nat Neurosci       Date:  2014-09-25       Impact factor: 24.884

Review 4.  The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.

Authors:  Roger Chou; Judith A Turner; Emily B Devine; Ryan N Hansen; Sean D Sullivan; Ian Blazina; Tracy Dana; Christina Bougatsos; Richard A Deyo
Journal:  Ann Intern Med       Date:  2015-02-17       Impact factor: 25.391

5.  The effect of acute morphine on delay discounting in dependent and non-dependent rats.

Authors:  Colin Harvey-Lewis; Keith B J Franklin
Journal:  Psychopharmacology (Berl)       Date:  2014-09-05       Impact factor: 4.530

6.  Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls.

Authors:  K N Kirby; N M Petry; W K Bickel
Journal:  J Exp Psychol Gen       Date:  1999-03

7.  Crowd-sourced assessment of surgical skills in cricothyrotomy procedure.

Authors:  Nava Aghdasi; Randall Bly; Lee W White; Blake Hannaford; Kris Moe; Thomas S Lendvay
Journal:  J Surg Res       Date:  2015-03-18       Impact factor: 2.192

8.  Effects of morphine and naltrexone on impulsive decision making in rats.

Authors:  Artur K Kieres; Kathryn A Hausknecht; Andrew M Farrar; Ashley Acheson; Harriet de Wit; Jerry B Richards
Journal:  Psychopharmacology (Berl)       Date:  2004-01-30       Impact factor: 4.530

9.  Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.

Authors:  Steven D Passik; Arvind Narayana; Ronghua Yang
Journal:  Pain Med       Date:  2014-03-25       Impact factor: 3.750

10.  Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010.

Authors:  Kristen Kenan; Karin Mack; Leonard Paulozzi
Journal:  Open Med       Date:  2012-04-10
View more
  8 in total

1.  The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use.

Authors:  Andrew S Huhn; D Andrew Tompkins; Kelly E Dunn
Journal:  Drug Alcohol Depend       Date:  2017-09-09       Impact factor: 4.492

2.  Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid Withdrawal.

Authors:  Andrew S Huhn; D Andrew Tompkins; Claudia M Campbell; Kelly E Dunn
Journal:  Pain Med       Date:  2019-10-01       Impact factor: 3.750

3.  To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients.

Authors:  D Andrew Tompkins; Andrew S Huhn; Patrick S Johnson; Michael T Smith; Eric C Strain; Robert R Edwards; Matthew W Johnson
Journal:  Addiction       Date:  2017-08-10       Impact factor: 6.526

4.  Sex differences in associations between delay discounting and expectancies for alcohol analgesia.

Authors:  Erin Ferguson; Darya Vitus; Michelle Williams; Molly Anderson; Lisa LaRowe; Joseph W Ditre; Bethany Stennett; Jeff Boissoneault
Journal:  Exp Clin Psychopharmacol       Date:  2021-08-19       Impact factor: 3.157

Review 5.  Factors mediating pain-related risk for opioid use disorder.

Authors:  Arbi Nazarian; S Stevens Negus; Thomas J Martin
Journal:  Neuropharmacology       Date:  2021-01-30       Impact factor: 5.250

6.  Pain-induced impulsivity is sexually dimorphic and mu-opioid receptor sensitive in rats.

Authors:  Nidia Espinoza Serrano; Samuel G Saputra; Javier Íbias; Matthew Company; Arbi Nazarian
Journal:  Psychopharmacology (Berl)       Date:  2021-08-24       Impact factor: 4.530

7.  Delay discounting of different outcomes: Review and theory.

Authors:  Amy L Odum; Ryan J Becker; Jeremy M Haynes; Ann Galizio; Charles C J Frye; Haylee Downey; Jonathan E Friedel; D M Perez
Journal:  J Exp Anal Behav       Date:  2020-03-08       Impact factor: 2.215

8.  High trait impulsivity potentiates the effects of chronic pain on impulsive behavior.

Authors:  Ana Margarida Cunha; Madalena Esteves; Joana Pereira-Mendes; Marco Rafael Guimarães; Armando Almeida; Hugo Leite-Almeida
Journal:  Neurobiol Pain       Date:  2019-12-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.